Warwick Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$581K Sell
4,520
-214
-5% -$25K 0.07% 73
2026
Q1
$569K Sell
4,734
-344
-7% -$39.7K 0.08% 68
2025
Q4
$534K Buy
5,078
+171
+3% +$16.1K 0.08% 76
2025
Q3
$412K Buy
4,907
+459
+10% +$37.8K 0.07% 91
2025
Q2
$352K Buy
4,448
+586
+15% +$46.6K 0.07% 83
2025
Q1
$347K Buy
3,862
+163
+4% +$15.2K 0.07% 79
2024
Q4
$368K Sell
3,699
-861
-19% -$88.8K 0.08% 67
2024
Q3
$518K Buy
4,560
+235
+5% +$27.9K 0.12% 49
2024
Q2
$535K Buy
4,325
+752
+21% +$96.9K 0.13% 57
2024
Q1
$471K Buy
3,573
+811
+29% +$100K 0.11% 60
2023
Q4
$301K Buy
2,762
+689
+33% +$71.5K 0.09% 61
2023
Q3
$213K Buy
2,073
+3
+0.1% +$323 0.08% 62
2023
Q2
$239K Buy
2,070
+17
+0.8% +$1.93K 0.09% 52
2023
Q1
$218K Buy
2,053
+23
+1% +$2.48K 0.09% 55
2022
Q4
$225K Buy
+2,030
New +$208K 0.09% 80

Other funds holding MRK

Warwick Investment Management's MRK Position: Q2 2026 in Review

Warwick Investment Management reduced its Merck (MRK) stake by 4.5% in Q2 2026, selling an estimated $25K and leaving 4,520 shares worth $581K. The position accounts for 0.07% of the portfolio, ranked #73.

Warwick Investment Management first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Warwick Investment Management held 4,520 shares of Merck worth $581K as of Q2 2026.
  • Warwick Investment Management sold 214 Merck shares in Q2 2026, an estimated $25K.
  • Merck made up 0.07% of Warwick Investment Management's portfolio in Q2 2026, its #73 holding.
  • Warwick Investment Management first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Warwick Investment Management's 13F filing for Q2 2026, filed 31 Jul 2026.